News
PoNS is a device that delivers mild electrical pulses to two nerves in your face and tongue. It’s a short-term treatment for adults with walking (gait) and motor control problems.
Hosted on MSN1mon
Helius Medical Technologies Secures Key Reimbursement Approval for PoNS Device - MSNThe PoNS Device is a non-invasive solution designed to improve walking in patients with gait deficit resulting from MS. This condition impacts mobility and quality of life, ...
The PoNS device’s use is limited to individuals 22 years and older with mild-to-moderate symptoms, potentially excluding a significant portion of the MS population and limiting market reach. FAQ ...
Hosted on MSN22d
Helius Medical Technologies Secures Fifth Major Payer Authorization for PoNS Device - MSNThe PoNS Device, priced at an out-of-network negotiated rate of $19,161, is a non-invasive treatment used to aid patients with multiple sclerosis (MS) in improving walking ability.
Aetna approves reimbursement for the PoNS Device, joining Anthem and United, enhancing access for MS patients. Quiver AI Summary. Helius Medical Technologies, Inc. has announced that Aetna ...
- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem ...
Aetna approves an out-of-network payment for Helius’ PoNS Device at a negotiated price of $18,350. The PoNS Device helps improve balance and walking in MS patients using mild tongue stimulation ...
Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait. Helius Medical Technologies, Inc.
The PoNS device is indicated for use in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (“MS”) ...
- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem ...
NEWTOWN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ: HSDT) will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99th annual American ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results